- Young adults using e-cigarettes experienced arterial stiffness and blood vessel damage similar to those who smoke traditional cigarettes.
- There was no evidence that using e-cigarettes reduced the cardiovascular injury associated with the use of combustible tobacco products.
- Researchers said longer-term research is needed to determine if vascular damage from e-cigarettes alone changes over time.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, April 29, 2020
DALLAS, April 29, 2020 — Using e-cigarettes damages the arteries and blood vessel function much like smoking traditional cigarettes, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association, and funded through the Tobacco Center of Regulatory Science of the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives.
“Many people believe e-cigarettes are safer than combustible cigarettes. In fact, most e-cigarette users say the primary reason they use e-cigarettes is because they think e-cigarettes pose less of a health risk,” said study author Jessica L. Fetterman, Ph.D., assistant professor of medicine at Boston University School of Medicine, Boston. “Meanwhile, the evidence from scientific studies is growing that e-cigarettes might not be the safer alternative to smoking traditional cigarettes when it comes to heart health. Our study adds to that evidence.”
Fetterman and colleagues studied over 400 men and women, ages 21 to 45 years, who had not been diagnosed with heart disease or heart disease risk factors. Study participants included 94 nonsmokers, 285 cigarette smokers, 36 e-cigarette users and 52 dual users who smoke combustible cigarettes and use e-cigarettes. Combustible cigarette smokers and dual users were older than non-smokers and e-cigarette users, while e-cigarette users were more likely to be younger, male and white. All e-cigarette users were former smokers of traditional cigarettes.
“We studied measures of blood vessel function in e-cigarette and dual users who had been using e-cigarettes for at least three months. Most studies to-date have looked at the impact of acute use of e-cigarettes on blood vessel function measured right before and after use, whereas our study evaluated blood vessel function in chronic e-cigarette use among young, healthy adults,” Fetterman said.
The researchers found that former smokers who switched to e-cigarettes and dual users had an augmentation index similar to traditional cigarette users, which means that their arteries were just as stiff.
“Stiffening of the arteries can cause damage to the small blood vessels, including capillaries, and puts additional stress on the heart, all of which can contribute to the development of heart disease,” Fetterman said.
The researchers also found that the cells that line the blood vessels, called endothelial cells, appeared to be equally as damaged whether people used e-cigarettes, combustible cigarettes or both.
“The endothelial cells from e-cigarette users or dual users produced less of the heart-protective compound nitric oxide, compared to non-tobacco users. Their cells also produced more reactive oxygen species, which cause damage to the parts of cells such as DNA and proteins,” Fetterman said. “Our study results suggest there is no evidence that the use of e-cigarettes reduces cardiovascular injury, dysfunction or harm associated with the use of combustible tobacco products.”
She noted longer-term studies are needed to determine if vascular damage from e-cigarettes alone changes over time.
Co-authors are Rachel J. Keith, Ph.D., A.P.R.N., A.N.P.-C.; Joseph N. Palmisano, M.P.H., M.A.; Kathleen L. McGlasson, M.P.H.; Robert M. Weisbrod, M.A.; Sana Majid, M.D.; Reena Bastin; Mary Margaret Stathos; Andrew Stokes, Ph.D.; Rose Marie Robertson, M.D.; Aruni Bhatnagar, Ph.D.; and Naomi M. Hamburg, M.D.
The National Heart, Lung, and Blood Institute of the National Institutes of Health and the U.S. Food and Drug Administration Center for Tobacco Products funded the study through grants to the American Heart Association, which works closely with investigators in institutions across the country to pursue research that can provide evidence to inform tobacco product regulation.
To learn more about the health impacts of e-cigarettes and other nicotine delivery systems, particularly on youth and young adults, the American Heart Association recently announced nearly $17 million in new research projects. The Association’s ENACT: End Nicotine Addiction in Children and Teens Research Initiative is fast-tracking groundbreaking projects over the next two years with research teams at Boston University, the Ohio State University and Yale University to fill a critical need for more definitive scientific knowledge in this area.
- Available multimedia is on right column of release link - https://newsroom.heart.org/news/e-cigarette-users-experience-vascular-damage-similar-to-that-of-smokers-of-combustible-cigarettes?preview=33afbf0440b20dd33bcec0750be2dc60
- After April 29, view the manuscript online.
- Vaping industry faces a triple threat - science, advocacy and community action
- The science about vaping dangers – and what we don’t know yet
- Smoking and Your Risk of Heart Disease and Stroke
- American Heart Association Forecasts Endgame for Tobacco and Nicotine Use
- How Smoking and Nicotine Damage Your Body
- Follow AHA/ASA news on Twitter @HeartNews
- Follow news from the Journal of the American Heart Association @JAHA_AHA
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Cathy Lewis: 214-706-1324; email@example.com
For Public Inquiries: 1-800-AHA-USA1 (242-8721)